Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Somewhat Bearish -35

Intuitive Surgical (NASDAQ:ISRG) Shares Gap Down on Analyst Downgrade

📉 JPMorgan Chase lowered its price target on Intuitive Surgical from $550.00 to $450.00, causing shares to gap down significantly.

📊 Deutsche Bank reduced its price target to $366.00 and issued a sell rating, adding to recent bearish analyst sentiment.

💰 Intuitive Surgical reported Q1 revenue of $2.77 billion, beating analyst estimates of $2.62 billion by $150 million.

📈 Earnings per share reached $2.50, surpassing the consensus estimate of $2.08 by a margin of $0.42.

🚀 Revenue grew 23% year-over-year, driven by strong demand for robotic-assisted surgical systems.

💵 The company achieved a net margin of 28.45% and a return on equity of 17.09% during the quarter.

🏦 Institutional ownership stands at 83.64%, indicating continued confidence from major investors.

📉 Hedge fund activity was mixed, with Newbridge Financial increasing its stake by 300% while others acquired new positions.

🎯 The average analyst price target remains $523.46, suggesting a Moderate Buy consensus despite recent cuts.

📉 Technical indicators show the stock trading below its 50-day moving average of $415.28 and 200-day average of $467.88.

Bullish Signals
  • Intuitive Surgical reported revenue of $2.77 billion, which beat analyst estimates of $2.62 billion.
  • The company posted earnings per share of $2.50, significantly beating the consensus estimate of $2.08.
  • Revenue grew 23% year-over-year, demonstrating strong top-line growth in its core business.
  • The firm achieved a healthy net margin of 28.45% and a return on equity of 17.09%.
  • Institutional ownership remains high at 83.64%, with several hedge funds increasing their stakes in Q4.
Risk Factors
  • JPMorgan Chase lowered its price target from $550.00 to $450.00, triggering a sharp gap down in the stock.
  • Deutsche Bank reduced its price target to $366.00 and assigned a sell rating to the company.
  • The stock is currently trading below both its 50-day moving average ($415.28) and 200-day moving average ($467.88).
  • Several other analysts, including Mizuho and Weiss Ratings, have issued neutral or hold ratings on the stock.
Full Analysis
Intuitive Surgical (NASDAQ:ISRG) shares experienced a significant gap down, opening at $365.03 after closing the previous session at $402.33. This decline was primarily triggered by JPMorgan Chase lowering its price target from $550.00 to $450.00, despite maintaining an overweight rating on the stock. The immediate market reaction saw shares trade around $355.92 with elevated volume of 2.26 million shares. The broader analyst sentiment surrounding ISRG has become increasingly mixed in recent weeks. While JPMorgan cut its target, Deutsche Bank reduced its price objective to $366.00 and assigned a sell rating. Conversely, HSBC lowered its target but maintained a buy rating, and Sanford Bernstein cut its target while keeping an outperform rating. The aggregate consensus remains a Moderate Buy with an average price target of $523.46. Despite the recent analyst downgrades, Intuitive Surgical reported strong quarterly fundamentals in late April. The company posted earnings per share of $2.50, beating estimates of $2.08, and generated revenue of $2.77 billion, which exceeded expectations of $2.62 billion. Revenue grew 23% year-over-year, supported by a net margin of 28.45% and a return on equity of 17.09%. Institutional ownership remains robust at 83.64%, with notable activity from hedge funds in the fourth quarter. Newbridge Financial Services Group Inc. increased its position by 300%, while Turning Point Benefit Group Inc. grew its stake by over 800%. The company maintains a market capitalization of $122.33 billion and trades at a P/E ratio of 39.57.